JPRN-UMIN000020134已完成未知
Prediction of the therapeutic response and adverse events to methotrexate by monitoring methotrexate-polyglutamates (MTX-PGs) concentration in erythrocytes in Japanese patients with rheumatoid arthritis (RA). - Study in Japanese patients with RA for prediction of the therapeutic response and adverse events to methotrexate by monitoring MTX-PG concentrations in erythrocytes.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have already been treated with Leflunomide and biologics. 2. Patients who can not be treated with MTX. 3. Patients who are pregnant, breast-feed, and desire to be pregnant.
研究者
相似试验
招募中
不适用
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosisDRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600
已完成
不适用
Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancerColorectal cancerJPRN-UMIN000021191Juntendo University Faculty of Medicine60
招募中
不适用
A study of factors which predicts the therapeutic effect of acotiamide on abdominal symptoms in patients with Functional dyspepsia.Functional dyspepsiaJPRN-UMIN000036265Akita University Graduate School of Medicine Department of Gastroenterology and Neurology200
已完成
不适用
Development of treatment effect prediction method of oral appliance therapy for obstructive sleep apnea syndromeObstructive sleep apnea syndromeJPRN-UMIN000014984Tokyo Medical and Dental University27
已完成
不适用
PREDICTION OF RESPONSE AND TOXICITY IN PATIENTS WHO RECEIVE CHEMOTHERAPY FOR BREAST CANCER, CORRELATIVE STUDY OF GENOMICS, PROTEOMICS AND PHARMACOGENOMY-C509 Breast, unspecifiedBreast, unspecifiedC509PER-079-05HOSSIER ONCOLOGY GROUP,